Tokyo Tape
Sign in
← M3

Quarterly report · Q2

2413.TEDINET S100PJMD
Period2022-04-01 → 2022-09-30
Filed2022-11-11
StandardIFRS
ConsolidatedYes
Data checks16 of 16 passed
Key figures · 61
MetricValuePeriodScopeSource row
Revenue¥112.6bn2022-04-01 → 2022-09-30Cons.Revenue IFRS
Revenue¥55.6bn2022-07-01 → 2022-09-30dCons.Revenue IFRS
Revenue¥208.2bn2021-04-01 → 2022-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥97.6bn2021-04-01 → 2021-09-30Cons.Revenue IFRS
Revenue¥51.2bn2021-07-01 → 2021-09-30dCons.Revenue IFRS
Operating income¥36.3bn2022-04-01 → 2022-09-30Cons.Operating profit loss IFRS
Operating income¥17.6bn2022-07-01 → 2022-09-30dCons.Operating profit loss IFRS
Operating income¥61.9bn2021-04-01 → 2021-09-30Cons.Operating profit loss IFRS
Operating income¥37.3bn2021-07-01 → 2021-09-30dCons.Operating profit loss IFRS
Profit before tax¥38.1bn2022-04-01 → 2022-09-30Cons.Profit loss before tax IFRS
Profit before tax¥18.3bn2022-07-01 → 2022-09-30dCons.Profit loss before tax IFRS
Profit before tax¥96.2bn2021-04-01 → 2022-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥62.2bn2021-04-01 → 2021-09-30Cons.Profit loss before tax IFRS
Profit before tax¥37.5bn2021-07-01 → 2021-09-30dCons.Profit loss before tax IFRS
Net income (owners)¥24.1bn2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥11.9bn2022-07-01 → 2022-09-30dCons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥63.8bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥40.8bn2021-04-01 → 2021-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥25.0bn2021-07-01 → 2021-09-30dCons.Profit loss attributable to owners of parent IFRS
Net income¥26.0bn2022-04-01 → 2022-09-30Cons.Profit loss IFRS
Net income¥12.5bn2022-07-01 → 2022-09-30dCons.Profit loss IFRS
Net income¥42.7bn2021-04-01 → 2021-09-30Cons.Profit loss IFRS
Net income¥25.8bn2021-07-01 → 2021-09-30dCons.Profit loss IFRS
Total assets¥377.7bnat 2022-09-30Cons.Assets IFRS
Total assets¥346.0bnat 2022-03-31Cons.Assets IFRS
Total assets¥308.4bnat 2021-09-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥86.4bnat 2022-09-30Cons.Liabilities IFRS
Total liabilities¥82.0bnat 2022-03-31Cons.Liabilities IFRS
Net assets / equity¥291.3bnat 2022-09-30Cons.Equity IFRS
Net assets / equity¥264.0bnat 2022-03-31Cons.Equity IFRS
Net assets / equity¥237.7bnat 2021-09-30Cons.Equity IFRS
Net assets / equity¥207.3bnat 2021-03-31dCons.Equity IFRS
Equity (owners)¥284.5bnat 2022-09-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥257.8bnat 2022-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥231.4bnat 2021-09-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥100.2bnat 2022-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥104.3bnat 2022-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥87.0bnat 2021-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥89.1bnat 2021-03-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥25.2bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥52.1bn2021-04-01 → 2022-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥18.6bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥18.1bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥23.4bn2021-04-01 → 2022-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥8.1bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥14.5bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥16.4bn2021-04-01 → 2022-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥13.0bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥35.442022-04-01 → 2022-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥17.582022-07-01 → 2022-09-30dCons.Basic earnings loss per share IFRS
EPS (basic)¥94.062021-04-01 → 2022-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥60.092021-04-01 → 2021-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥36.862021-07-01 → 2021-09-30dCons.Basic earnings loss per share IFRS
EPS (diluted)¥35.422022-04-01 → 2022-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥17.572022-07-01 → 2022-09-30dCons.Diluted earnings loss per share IFRS
EPS (diluted)¥93.982021-04-01 → 2022-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥60.042021-04-01 → 2021-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥36.832021-07-01 → 2021-09-30dCons.Diluted earnings loss per share IFRS
Equity ratio75.3%at 2022-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio74.5%at 2022-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio75.0%at 2021-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 107
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-09-30−¥2.8bn
Reconciling Itemsreconcilingrevenue2022-07-01 → 2022-09-30−¥1.1bn
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-09-30−¥2.8bn
Reconciling Itemsreconcilingrevenue intersegment2022-07-01 → 2022-09-30−¥1.1bn
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-09-30−¥701m
Reconciling Itemsreconcilingsegment profit2022-07-01 → 2022-09-30−¥231m
jpcrp040300-q2r_E05425-000Career Solutionreportable segmentrevenue2022-04-01 → 2022-09-30¥8.4bn
jpcrp040300-q2r_E05425-000Career Solutionreportable segmentrevenue2022-07-01 → 2022-09-30¥2.9bn
jpcrp040300-q2r_E05425-000Career Solutionreportable segmentrevenue external2022-04-01 → 2022-09-30¥7.9bn
jpcrp040300-q2r_E05425-000Career Solutionreportable segmentrevenue external2022-07-01 → 2022-09-30¥2.7bn
jpcrp040300-q2r_E05425-000Career Solutionreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥445m
jpcrp040300-q2r_E05425-000Career Solutionreportable segmentrevenue intersegment2022-07-01 → 2022-09-30¥179m
jpcrp040300-q2r_E05425-000Career Solutionreportable segmentsegment profit2022-04-01 → 2022-09-30¥3.5bn
jpcrp040300-q2r_E05425-000Career Solutionreportable segmentsegment profit2022-07-01 → 2022-09-30¥634m
jpcrp040300-q2r_E05425-000Evidence Solutionreportable segmentrevenue2022-04-01 → 2022-09-30¥14.0bn
jpcrp040300-q2r_E05425-000Evidence Solutionreportable segmentrevenue2022-07-01 → 2022-09-30¥6.8bn
jpcrp040300-q2r_E05425-000Evidence Solutionreportable segmentrevenue external2022-04-01 → 2022-09-30¥13.7bn
jpcrp040300-q2r_E05425-000Evidence Solutionreportable segmentrevenue external2022-07-01 → 2022-09-30¥6.6bn
jpcrp040300-q2r_E05425-000Evidence Solutionreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥347m
jpcrp040300-q2r_E05425-000Evidence Solutionreportable segmentrevenue intersegment2022-07-01 → 2022-09-30¥185m
jpcrp040300-q2r_E05425-000Evidence Solutionreportable segmentsegment profit2022-04-01 → 2022-09-30¥4.2bn
jpcrp040300-q2r_E05425-000Evidence Solutionreportable segmentsegment profit2022-07-01 → 2022-09-30¥2.0bn
jpcrp040300-q2r_E05425-000Medical Platformreportable segmentrevenue2022-04-01 → 2022-09-30¥42.5bn
jpcrp040300-q2r_E05425-000Medical Platformreportable segmentrevenue2022-07-01 → 2022-09-30¥22.3bn
jpcrp040300-q2r_E05425-000Medical Platformreportable segmentrevenue external2022-04-01 → 2022-09-30¥40.9bn
jpcrp040300-q2r_E05425-000Medical Platformreportable segmentrevenue external2022-07-01 → 2022-09-30¥21.6bn
jpcrp040300-q2r_E05425-000Medical Platformreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥1.6bn
jpcrp040300-q2r_E05425-000Medical Platformreportable segmentrevenue intersegment2022-07-01 → 2022-09-30¥664m
jpcrp040300-q2r_E05425-000Medical Platformreportable segmentsegment profit2022-04-01 → 2022-09-30¥18.8bn
jpcrp040300-q2r_E05425-000Medical Platformreportable segmentsegment profit2022-07-01 → 2022-09-30¥10.0bn
jpcrp040300-q2r_E05425-000Overseasreportable segmentrevenue2022-04-01 → 2022-09-30¥30.2bn
jpcrp040300-q2r_E05425-000Overseasreportable segmentrevenue2022-07-01 → 2022-09-30¥15.3bn
jpcrp040300-q2r_E05425-000Overseasreportable segmentrevenue external2022-04-01 → 2022-09-30¥30.2bn
jpcrp040300-q2r_E05425-000Overseasreportable segmentrevenue external2022-07-01 → 2022-09-30¥15.3bn
jpcrp040300-q2r_E05425-000Overseasreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥4m
jpcrp040300-q2r_E05425-000Overseasreportable segmentrevenue intersegment2022-07-01 → 2022-09-30¥2m
jpcrp040300-q2r_E05425-000Overseasreportable segmentsegment profit2022-04-01 → 2022-09-30¥8.1bn
jpcrp040300-q2r_E05425-000Overseasreportable segmentsegment profit2022-07-01 → 2022-09-30¥4.1bn
jpcrp040300-q2r_E05425-000Site Solutionreportable segmentrevenue2022-04-01 → 2022-09-30¥18.8bn
jpcrp040300-q2r_E05425-000Site Solutionreportable segmentrevenue2022-07-01 → 2022-09-30¥8.6bn
jpcrp040300-q2r_E05425-000Site Solutionreportable segmentrevenue external2022-04-01 → 2022-09-30¥18.5bn
jpcrp040300-q2r_E05425-000Site Solutionreportable segmentrevenue external2022-07-01 → 2022-09-30¥8.6bn
jpcrp040300-q2r_E05425-000Site Solutionreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥304m
jpcrp040300-q2r_E05425-000Site Solutionreportable segmentsegment profit2022-04-01 → 2022-09-30¥2.3bn
jpcrp040300-q2r_E05425-000Site Solutionreportable segmentsegment profit2022-07-01 → 2022-09-30¥865m
—segment totalrevenue2022-04-01 → 2022-09-30¥113.9bn
—segment totalrevenue2022-07-01 → 2022-09-30¥55.9bn
—segment totalrevenue external2022-04-01 → 2022-09-30¥111.2bn
—segment totalrevenue external2022-07-01 → 2022-09-30¥54.8bn
—segment totalrevenue intersegment2022-04-01 → 2022-09-30¥2.7bn
—segment totalrevenue intersegment2022-07-01 → 2022-09-30¥1.0bn
—segment totalsegment profit2022-04-01 → 2022-09-30¥36.9bn
—segment totalsegment profit2022-07-01 → 2022-09-30¥17.6bn
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-09-30−¥2.5bn
Reconciling Itemsreconcilingrevenue2021-07-01 → 2021-09-30−¥1.5bn
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-09-30−¥2.5bn
Reconciling Itemsreconcilingrevenue intersegment2021-07-01 → 2021-09-30−¥1.5bn
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-09-30−¥520m
Reconciling Itemsreconcilingsegment profit2021-07-01 → 2021-09-30−¥376m
jpcrp040300-q2r_E05425-000Career Solutionreportable segmentrevenue2021-04-01 → 2021-09-30¥8.2bn
jpcrp040300-q2r_E05425-000Career Solutionreportable segmentrevenue2021-07-01 → 2021-09-30¥3.3bn
jpcrp040300-q2r_E05425-000Career Solutionreportable segmentrevenue external2021-04-01 → 2021-09-30¥7.8bn
jpcrp040300-q2r_E05425-000Career Solutionreportable segmentrevenue external2021-07-01 → 2021-09-30¥3.0bn
jpcrp040300-q2r_E05425-000Career Solutionreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥364m
jpcrp040300-q2r_E05425-000Career Solutionreportable segmentrevenue intersegment2021-07-01 → 2021-09-30¥338m
jpcrp040300-q2r_E05425-000Career Solutionreportable segmentsegment profit2021-04-01 → 2021-09-30¥3.4bn
jpcrp040300-q2r_E05425-000Career Solutionreportable segmentsegment profit2021-07-01 → 2021-09-30¥979m
jpcrp040300-q2r_E05425-000Evidence Solutionreportable segmentrevenue2021-04-01 → 2021-09-30¥10.1bn
jpcrp040300-q2r_E05425-000Evidence Solutionreportable segmentrevenue2021-07-01 → 2021-09-30¥5.3bn
jpcrp040300-q2r_E05425-000Evidence Solutionreportable segmentrevenue external2021-04-01 → 2021-09-30¥9.6bn
jpcrp040300-q2r_E05425-000Evidence Solutionreportable segmentrevenue external2021-07-01 → 2021-09-30¥5.0bn
jpcrp040300-q2r_E05425-000Evidence Solutionreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥483m
jpcrp040300-q2r_E05425-000Evidence Solutionreportable segmentrevenue intersegment2021-07-01 → 2021-09-30¥288m
jpcrp040300-q2r_E05425-000Evidence Solutionreportable segmentsegment profit2021-04-01 → 2021-09-30¥2.1bn
jpcrp040300-q2r_E05425-000Evidence Solutionreportable segmentsegment profit2021-07-01 → 2021-09-30¥1.2bn
jpcrp040300-q2r_E05425-000Medical Platformreportable segmentrevenue2021-04-01 → 2021-09-30¥38.4bn
jpcrp040300-q2r_E05425-000Medical Platformreportable segmentrevenue2021-07-01 → 2021-09-30¥19.5bn
jpcrp040300-q2r_E05425-000Medical Platformreportable segmentrevenue external2021-04-01 → 2021-09-30¥37.1bn
jpcrp040300-q2r_E05425-000Medical Platformreportable segmentrevenue external2021-07-01 → 2021-09-30¥18.8bn
jpcrp040300-q2r_E05425-000Medical Platformreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥1.3bn
jpcrp040300-q2r_E05425-000Medical Platformreportable segmentrevenue intersegment2021-07-01 → 2021-09-30¥622m
jpcrp040300-q2r_E05425-000Medical Platformreportable segmentsegment profit2021-04-01 → 2021-09-30¥16.7bn
jpcrp040300-q2r_E05425-000Medical Platformreportable segmentsegment profit2021-07-01 → 2021-09-30¥8.5bn
jpcrp040300-q2r_E05425-000Overseasreportable segmentrevenue2021-04-01 → 2021-09-30¥24.4bn
jpcrp040300-q2r_E05425-000Overseasreportable segmentrevenue2021-07-01 → 2021-09-30¥11.7bn
jpcrp040300-q2r_E05425-000Overseasreportable segmentrevenue external2021-04-01 → 2021-09-30¥24.4bn
jpcrp040300-q2r_E05425-000Overseasreportable segmentrevenue external2021-07-01 → 2021-09-30¥11.7bn
jpcrp040300-q2r_E05425-000Overseasreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥12m
jpcrp040300-q2r_E05425-000Overseasreportable segmentrevenue intersegment2021-07-01 → 2021-09-30¥1m
jpcrp040300-q2r_E05425-000Overseasreportable segmentsegment profit2021-04-01 → 2021-09-30¥38.1bn
jpcrp040300-q2r_E05425-000Overseasreportable segmentsegment profit2021-07-01 → 2021-09-30¥25.2bn
jpcrp040300-q2r_E05425-000Site Solutionreportable segmentrevenue2021-04-01 → 2021-09-30¥17.5bn
jpcrp040300-q2r_E05425-000Site Solutionreportable segmentrevenue2021-07-01 → 2021-09-30¥12.2bn
jpcrp040300-q2r_E05425-000Site Solutionreportable segmentrevenue external2021-04-01 → 2021-09-30¥17.2bn
jpcrp040300-q2r_E05425-000Site Solutionreportable segmentrevenue external2021-07-01 → 2021-09-30¥11.9bn
jpcrp040300-q2r_E05425-000Site Solutionreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥238m
jpcrp040300-q2r_E05425-000Site Solutionreportable segmentrevenue intersegment2021-07-01 → 2021-09-30¥238m
jpcrp040300-q2r_E05425-000Site Solutionreportable segmentsegment profit2021-04-01 → 2021-09-30¥2.6bn
jpcrp040300-q2r_E05425-000Site Solutionreportable segmentsegment profit2021-07-01 → 2021-09-30¥2.0bn
—segment totalrevenue2021-04-01 → 2021-09-30¥98.6bn
—segment totalrevenue2021-07-01 → 2021-09-30¥52.0bn
—segment totalrevenue external2021-04-01 → 2021-09-30¥96.2bn
—segment totalrevenue external2021-07-01 → 2021-09-30¥50.5bn
—segment totalrevenue intersegment2021-04-01 → 2021-09-30¥2.4bn
—segment totalrevenue intersegment2021-07-01 → 2021-09-30¥1.5bn
—segment totalsegment profit2021-04-01 → 2021-09-30¥62.9bn
—segment totalsegment profit2021-07-01 → 2021-09-30¥37.9bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 824
ItemContextValueUnit
Other comprehensive income IFRSPrior1YTDDuration_NonControllingInterestsIFRSMember6000000JPY
Other comprehensive income IFRSPrior1YTDDuration212000000JPY
Comprehensive income IFRSPrior1YTDDuration_ShareCapitalIFRSMember－JPY
Comprehensive income IFRSPrior1YTDDuration_CapitalSurplusIFRSMember－JPY
Comprehensive income IFRSPrior1YTDDuration_TreasurySharesIFRSMember－JPY
Comprehensive income IFRSPrior1YTDDuration_OtherComponentsOfEquityIFRSMember206000000JPY
Comprehensive income IFRSPrior1YTDDuration_RetainedEarningsIFRSMember40788000000JPY
Comprehensive income IFRSPrior1YTDDuration_EquityAttributableToOwnersOfParentIFRSMember40995000000JPY
Comprehensive income IFRSPrior1YTDDuration_NonControllingInterestsIFRSMember1964000000JPY
Comprehensive income IFRSPrior1YTDDuration42959000000JPY
Dividends ss IFRSPrior1YTDDuration_RetainedEarningsIFRSMember-8145000000JPY
Dividends ss IFRSPrior1YTDDuration_EquityAttributableToOwnersOfParentIFRSMember-8145000000JPY
Dividends ss IFRSPrior1YTDDuration_NonControllingInterestsIFRSMember-1291000000JPY
Dividends ss IFRSPrior1YTDDuration-9436000000JPY
Changes in ownership interest in subsidiaries ss IFRSPrior1YTDDuration_CapitalSurplusIFRSMember-1428000000JPY
Changes in ownership interest in subsidiaries ss IFRSPrior1YTDDuration_EquityAttributableToOwnersOfParentIFRSMember-1428000000JPY
Changes in ownership interest in subsidiaries ss IFRSPrior1YTDDuration_NonControllingInterestsIFRSMember-387000000JPY
Changes in ownership interest in subsidiaries ss IFRSPrior1YTDDuration-1815000000JPY
Disposal of subsidiaries ss IFRSPrior1YTDDuration_EquityAttributableToOwnersOfParentIFRSMember－JPY
Disposal of subsidiaries ss IFRSPrior1YTDDuration_NonControllingInterestsIFRSMember-1486000000JPY
Disposal of subsidiaries ss IFRSPrior1YTDDuration-1486000000JPY
Share based payment transactions ss IFRSPrior1YTDDuration_ShareCapitalIFRSMember31000000JPY
Share based payment transactions ss IFRSPrior1YTDDuration_CapitalSurplusIFRSMember32000000JPY
Share based payment transactions ss IFRSPrior1YTDDuration_OtherComponentsOfEquityIFRSMember106000000JPY
Share based payment transactions ss IFRSPrior1YTDDuration_EquityAttributableToOwnersOfParentIFRSMember169000000JPY
Share based payment transactions ss IFRSPrior1YTDDuration169000000JPY
Transfer from other components of equity to retained earnings ss IFRSPrior1YTDDuration_OtherComponentsOfEquityIFRSMember-27000000JPY
Transfer from other components of equity to retained earnings ss IFRSPrior1YTDDuration_RetainedEarningsIFRSMember27000000JPY
Transfer from other components of equity to retained earnings ss IFRSPrior1YTDDuration_EquityAttributableToOwnersOfParentIFRSMember－JPY
Transfer from other components of equity to retained earnings ss IFRSPrior1YTDDuration－JPY
Total transactions with owners IFRSPrior1YTDDuration_ShareCapitalIFRSMember31000000JPY
Total transactions with owners IFRSPrior1YTDDuration_CapitalSurplusIFRSMember-1396000000JPY
Total transactions with owners IFRSPrior1YTDDuration_TreasurySharesIFRSMember－JPY
Total transactions with owners IFRSPrior1YTDDuration_OtherComponentsOfEquityIFRSMember79000000JPY
Total transactions with owners IFRSPrior1YTDDuration_RetainedEarningsIFRSMember-8118000000JPY
Total transactions with owners IFRSPrior1YTDDuration_EquityAttributableToOwnersOfParentIFRSMember-9404000000JPY
Total transactions with owners IFRSPrior1YTDDuration_NonControllingInterestsIFRSMember-3164000000JPY
Total transactions with owners IFRSPrior1YTDDuration-12568000000JPY
Equity IFRSPrior1QuarterInstant_ShareCapitalIFRSMember29067000000JPY
Equity IFRSPrior1QuarterInstant_CapitalSurplusIFRSMember30818000000JPY
Equity IFRSPrior1QuarterInstant_TreasurySharesIFRSMember-36000000JPY
Equity IFRSPrior1QuarterInstant_OtherComponentsOfEquityIFRSMember1734000000JPY
Equity IFRSPrior1QuarterInstant_RetainedEarningsIFRSMember169821000000JPY
Equity IFRSPrior1QuarterInstant_EquityAttributableToOwnersOfParentIFRSMember231404000000JPY
Equity IFRSPrior1QuarterInstant_NonControllingInterestsIFRSMember6248000000JPY
Equity IFRSPrior1QuarterInstant237651000000JPY
Equity IFRSPrior1YearInstant_ShareCapitalIFRSMember29129000000JPY
Equity IFRSPrior1YearInstant_CapitalSurplusIFRSMember29704000000JPY
Equity IFRSPrior1YearInstant_TreasurySharesIFRSMember-36000000JPY
Equity IFRSPrior1YearInstant_OtherComponentsOfEquityIFRSMember6131000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 16 of 16 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-09-30pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2021-07-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-07-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-09-30pass
statement vs summary · revenueconsolidated 2021-07-01/2021-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2022-07-01/2022-09-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-09-30pass